L
Lee M. Ellis
Researcher at University of Texas MD Anderson Cancer Center
Publications - 364
Citations - 33895
Lee M. Ellis is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Angiogenesis & Vascular endothelial growth factor. The author has an hindex of 105, co-authored 355 publications receiving 31804 citations.
Papers
More filters
Journal ArticleDOI
Drug development: Raise standards for preclinical cancer research
C. Glenn Begley,Lee M. Ellis +1 more
TL;DR: C. Glenn Begley and Lee M. Ellis propose how methods, publications and incentives must change if patients are to benefit.
Journal ArticleDOI
Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells *
TL;DR: It is demonstrated that exposure of HCT116 human colon carcinoma cells to IGF-1 induces the expression of HIF-1α, the regulated subunit of hypoxia-inducible factor 1, a known transactivator of the VEGF gene.
Journal ArticleDOI
Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance.
Scott Kopetz,Paulo M. Hoff,Jeffrey S. Morris,Robert A. Wolff,Cathy Eng,Katrina Y. Glover,Rosie Adinin,Michael J. Overman,Vincete Valero,Sijin Wen,Christopher H. Lieu,Shaoyu Yan,Hai T. Tran,Lee M. Ellis,James L. Abbruzzese,John V. Heymach +15 more
TL;DR: Efficacy and tolerability of FOLFIRI + B appeared favorable to historical controls in this single arm study, and there was a shift in balance of CAFs, with a rise in alternate pro-angiogenic cytokines and myeloid recruitment factors in subsets of patients that may represent mechanisms of resistance.
Journal ArticleDOI
Endothelial Cells Promote the Colorectal Cancer Stem Cell Phenotype through a Soluble Form of Jagged-1
Jia Lu,Xiangcang Ye,Fan Fan,Ling Xia,Rajat Bhattacharya,Seth Bellister,Federico Tozzi,Eric Sceusi,Yunfei Zhou,Isamu Tachibana,Dipen M. Maru,David H. Hawke,Janusz Rak,Sendurai A. Mani,Patrick A. Zweidler-McKay,Lee M. Ellis +15 more
TL;DR: It is shown that, without direct cell-cell contact, ECs secrete factors that promoted the CSC phenotype in CRC cells via Notch activation, and ECs play an active role in promoting Notch signaling and the C SC phenotype by secreting soluble Jagged-1.
Journal ArticleDOI
Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin‐based chemotherapy for colorectal liver metastases
Dario Ribero,Huamin Wang,Matteo Donadon,Daria Zorzi,Melanie B. Thomas,Cathy Eng,David Z. Chang,Steven A. Curley,Eddie K. Abdalla,Lee M. Ellis,Jean Nicolas Vauthey +10 more
TL;DR: The current study evaluated the effect of bevacizumab added to fluoropyrimidine‐plus‐oxaliplatin (5FU/OX) chemotherapy for colorectal liver metastases (CLM) on the pathologic response and nontumorous liver histology.